Last year the United Nations commissioned a special health care panel to study the barriers to access to those drugs, and the group is expected to release its findings within days. And yet there remains little suspense as to what the panel, formally designated the “High-Level Panel on Access to Medicines,” will propose: erase the rights of inventors. From its inception, the panel misaligned global intellectual property opposite human rights in a false dichotomy so contrived as to remove any doubt the United Nations is not serious about addressing the uniquely pressing consideration of access to critical medicines.
Read Full Article »
